ArticleJournal of inherited metabolic disease2022

Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.

Cécile Boulanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.